LifeMD Cost of Revenue vs Enterprise Value Analysis
LFMD Stock | USD 10.21 0.34 3.44% |
LifeMD financial indicator trend analysis is infinitely more than just investigating LifeMD Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LifeMD Inc is a good investment. Please check the relationship between LifeMD Cost Of Revenue and its Enterprise Value accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Cost Of Revenue vs Enterprise Value
Cost of Revenue vs Enterprise Value Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LifeMD Inc Cost of Revenue account and Enterprise Value. At this time, the significance of the direction appears to have very strong relationship.
The correlation between LifeMD's Cost of Revenue and Enterprise Value is 0.89. Overlapping area represents the amount of variation of Cost of Revenue that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of LifeMD Inc, assuming nothing else is changed. The correlation between historical values of LifeMD's Cost of Revenue and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost of Revenue of LifeMD Inc are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Cost of Revenue i.e., LifeMD's Cost of Revenue and Enterprise Value go up and down completely randomly.
Correlation Coefficient | 0.89 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Cost Of Revenue
Cost of Revenue is found on LifeMD Inc income statement and represents the costs associated with goods and services LifeMD provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Enterprise Value
Enterprise Value (or EV) is usually referred to as LifeMD theoretical takeover price. In the event of an acquisition, an acquirer would have to take on LifeMD Inc debt, but would also pocket its cash. Enterprise Value is more accurate representation of LifeMD value than its market capitalization because it takes into account all of LifeMD Inc existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Most indicators from LifeMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At present, LifeMD's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 449.4 K, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.32.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 74.9M | 100.4M | 126.0M | 132.3M | Total Revenue | 92.9M | 119.0M | 152.5M | 160.2M |
LifeMD fundamental ratios Correlations
Click cells to compare fundamentals
LifeMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
LifeMD fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 3.4M | 13.1M | 49.9M | 25.7M | 58.5M | 61.4M | |
Short Long Term Debt Total | 844.7K | 1.1M | 1.8M | 4.1M | 18.9M | 19.9M | |
Other Current Liab | 3.1M | 1.4M | 11.6M | 12.2M | 13.9M | 14.6M | |
Total Current Liabilities | 4.0M | 13.5M | 22.8M | 31.4M | 34.8M | 36.5M | |
Total Stockholder Equity | (988.2K) | 1.4M | 26.9M | (6.8M) | 3.5M | 2.1M | |
Net Debt | (261.9K) | (8.1M) | (39.5M) | 168.5K | (14.2M) | (13.5M) | |
Retained Earnings | (16.6M) | (80.2M) | (141.9M) | (190.6M) | (214.3M) | (203.6M) | |
Accounts Payable | 3.1M | 10.4M | 9.1M | 10.1M | 11.1M | 11.6M | |
Cash | 1.1M | 9.2M | 41.3M | 4.0M | 33.1M | 34.8M | |
Non Current Assets Total | 699.1K | 990.3K | 5.0M | 14.4M | 15.9M | 16.7M | |
Cash And Short Term Investments | 1.1M | 9.2M | 41.3M | 4.0M | 33.1M | 34.8M | |
Net Receivables | 97.4K | 648.4K | 980.1K | 2.8M | 5.3M | 5.5M | |
Common Stock Total Equity | 534.0K | 234.3K | 307.0K | 315.5K | 362.9K | 377.1K | |
Common Stock Shares Outstanding | 9.9M | 14.3M | 27.0M | 31.0M | 33.9M | 35.6M | |
Liabilities And Stockholders Equity | 3.4M | 13.1M | 49.9M | 25.7M | 58.5M | 61.4M | |
Non Current Liabilities Total | 600.0K | 385.3K | 1.3M | 1.6M | 18.1M | 19.0M | |
Inventory | 950.1K | 1.3M | 1.6M | 3.7M | 2.8M | 2.9M | |
Other Stockholder Equity | 15.1M | 77.6M | 164.4M | 178.9M | 217.4M | 228.3M | |
Total Liab | 4.6M | 13.9M | 24.1M | 33.0M | 52.9M | 55.6M | |
Total Current Assets | 2.7M | 12.1M | 44.9M | 11.3M | 42.6M | 44.7M | |
Short Term Debt | 814.7K | 779.1K | 670.9K | 3.6M | 930.8K | 715.0K | |
Common Stock | 534.0K | 234.3K | 307.0K | 315.5K | 383.6K | 380.6K | |
Current Deferred Revenue | 109.6K | 916.9K | 1.5M | 5.5M | 8.8M | 9.3M | |
Other Current Assets | 443.0K | 154.9K | 793.2K | 687.0K | 1.4M | 1.5M | |
Net Tangible Assets | (1.7M) | (3.0M) | 19.7M | (19.5M) | (17.6M) | (16.7M) | |
Net Invested Capital | (173.5K) | (1.5M) | 22.8M | (8.6M) | 21.8M | 22.8M | |
Short Long Term Debt | 814.7K | 779.1K | 63.4K | 2.8M | 327.6K | 311.2K | |
Net Working Capital | (1.2M) | (1.4M) | 22.1M | (20.1M) | 7.8M | 8.2M | |
Capital Stock | 534.0K | 3.9M | 4.4M | 4.9M | 383.7K | 364.5K | |
Intangible Assets | 675.5K | 715.8K | 3.0M | 12.7M | 14.8M | 15.5M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards LifeMD in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, LifeMD's short interest history, or implied volatility extrapolated from LifeMD options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for LifeMD Stock analysis
When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is LifeMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.70) | Revenue Per Share 4.499 | Quarterly Revenue Growth 0.595 | Return On Assets (0.22) | Return On Equity (7.82) |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.